RMA of Pennsylvania announces exceptional InVitro Fertilization success rates
Allentown, PA (PRWEB) March 11, 2015 -- Reproductive Medicine Associates of Pennsylvania (RMAPA) in Allentown, Pa. is pleased to announce, according to a report released on Tuesday, March 3, 2015 by the Society of Assisted Reproductive Technology (SART), an 81.8% (18/22) success rate for InVitro Fertilization (IVF) embryo transfers resulting in a live birth, for women under 35. The national average for this age group is 47.7%.*
The 2013 rate is reported by SART, the primary organization of professionals dedicated to the practice of Assisted Reproductive Technologies in the United States. RMAPA's full Clinic Summary Report can be viewed at http://www.sart.org.
RMAPA has consistently achieved IVF success rates, significantly above the national average, since its inception in 2008 by Dr. Wendy J. Schillings, Dr. Paul A. Bergh, Dr. Richard T. Scott and Dr. Michael R. Drews, RMAPA credits its increase in successful pregnancies to participation in research studies for advancement in the areas of blastocyst embryo transfer, Comprehensive Chromosomal Screening (CCS), trophectoderm biopsy of embryos for genetic testing, and Single Embryo Transfer.
“Innovations, like CCS, allow us the opportunity to test embryos prior to transfer, which not only better ensures the health of the embryo, but also increases the chance of successful pregnancy and delivery,” explains Dr. Wendy J. Schillings, M.D., FACOG.
About Reproductive Medicine Associates of Pennsylvania
Working as a team, the entire staff of RMAPA constantly strives to provide their patients with the highest, most technology advanced level of support and treatment available in the industry today. RMAPA’s services include Ovulation Induction, In Vitro Fertilization (IVF), Artificial Insemination (IUI), and Fertility Preservation.
CONTACT: Melissa Fink, RMAPA at 610-820-6888, mfink(AT)rmanj.com or visit rmapa.com.
*A comparison of clinic success rates may not be meaningful because patient medical characteristics, treatment approaches and entrance criteria for ART may vary from clinic to clinic.
Natalie Rutman, 3Seed Marketing & Design Studio, http://www.3seedmarketing.com, +1 484-646-9300, [email protected]
Share this article